TAILORED-CHIP Trial: Time-Dependent Antiplatelet Therapy in High-Risk PCI
Ahmed Bennis, Professor of Cardiology, shared a post on X:
”Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trial
TAILORED-CHIP trial is an investigator-initiated, multicentre, prospective randomised trial to evaluate the efficacy and safety of a time-dependent tailored antiplatelet therapy with an early (<6 months post-PCI) escalation (low-dose ticagrelor at 60 mg twice daily plus aspirin) and a late (>6 months post-PCI) de-escalation (clopidogrel monotherapy) in patients undergoing complex high-risk PCI as compared with standard DAPT (clopidogrel plus aspirin for 12 months).”
Read the full article here.
Title: Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trial
Authors: Hanbit Park, Do-Yoon Kang, Jung-Min Ahn, Sung-Cheol Yun, Kyoung-Ha Park, Se-Hun Kang, Jon Suh, Jang-Whan Bae, Sangwoo Park, Jang Hyun Cho, Jung-Won Suh, Bong-Ki Lee, Seung-Woon Rha, Hoyoun Won, Jae-Sik Jang, Moo Hyun Kim, Cheol Hyun Lee, Young Keun Ahn, Jun-Hyok Oh, Jae-Seok Bae, Chul Soo Park, Jaewoong Choi, Jin-Bae Lee, Se-Whan Lee, Sung-Ho Hur, Osung Kwon, Seung-Jung Park, Duk-Woo Park; on behalf of the TAILORED-CHIP trial investigators
Stay updated with Hemostasis Today.
-
Mar 1, 2026, 13:17Michael Makris։ Extraterrestrial Regolith as a Trigger of the Intrinsic Coagulation Pathway
-
Mar 1, 2026, 13:11Strategic Planning Day to Shape The Future of Thrombosis and Haemostasis – THANZ
-
Mar 1, 2026, 13:06Simon Senanu: Not Every Thrombocytopenia Is Real
-
Mar 1, 2026, 12:53Kevin Tang: Evolving Burden of CVD Across Asia and Its Broader Implications for Global Health Policy
-
Mar 1, 2026, 12:02Hassan Raza: Building Sustainable Support for People with Bleeding Disorders in Pakistan
-
Mar 1, 2026, 11:40Naradja Wissmar: Raised IL-32 as a Hint to Long-Term Immune Activation Post-COVID
-
Mar 1, 2026, 11:10Mehran Ghasemzadeh: A Novel Panel Bridging Platelet Function and Clinical Presentation in Chronic ITP
-
Mar 1, 2026, 10:47Tagreed Alkaltham: In Transfusion Medicine, Every Reaction Deserves An Answer
-
Mar 1, 2026, 10:31Deborah Siegal Explores ARTESiA in The CLOT Conversation’s Latest Episode